EU launches strategies to strengthen crisis readiness and health security
The Medical Countermeasures Strategy focuses on strengthening the EU’s preparedness for health crises
The Medical Countermeasures Strategy focuses on strengthening the EU’s preparedness for health crises
The pharmaceuticals laboratory supports North Asia with formulation development, reverse engineering, troubleshooting, and analysis for various dosage forms
Anti-cancer patent now validated in Spain, the UK, and as a Unitary Patent covering multiple EU member states
Changhua site meets international regulatory standards for global medical applications
This collaboration ensures that patients receive comprehensive care, including emotional and psychological support throughout their fertility journey
Enflosina is a long-acting monoclonal antibody that provides direct protection for up to 5 months
Honeywell Aclar film technology will enable Evertis to develop high-quality barrier packaging solutions
In Q4 FY25, our pharmaceutical business reported revenue growth of 20% to Rs 351 crore and EBIT growth of 65% to Rs 55 croe, on QoQ basis
The Protect VL project was born out of a vision to reduce the environmental footprint of medical devices
Subscribe To Our Newsletter & Stay Updated